Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TC BioPharm (Holdings) plc - Warrants (NQ: TCBPW )

0.0150 +0.0024 (+19.05%)
Streaming Delayed Price Updated: 3:03 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about TC BioPharm (Holdings) plc - Warrants

TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemia
TC Biopharm (NASDAQ: TCBP) (NASDAQ: TCBPW) recently announced the dosing of its first three patients within its Phase 2b clinical trial of OmnImmune®, 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.